Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486705 · ClinicalTrials.gov registry record · Phase 1
Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD
A Phase 1 study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- Phase 1
- Development phase
- 242
- Enrollment target
NCT02486705: Completed Phase 1 study, sponsored by VA Palo Alto Health Care System.
NCT02486705 is a Phase 1 study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 242 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (303% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486705, a Phase 1 study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 242 participants
- Enrollment target
Study Summary
The proposed pilot study is designed to test the feasibility, acceptability, and potential effectiveness of a mobile phone application (app) developed by the VA National Center for PTSD (VA NCPTSD) for use by family members of those with Posttraumatic Stress Disorder (PTSD). The primary objective of the proposed study is to assess whether family members of veterans with PTSD find the PTSD Family Coach app to be satisfactory and feasible to use. Secondary objectives are to determine if use of the app increases family members' self-efficacy and their ability to manage their own life stress, which may in part be the result of living with someone who has PTSD.
Interventions
- BEHAVIORAL PTSD Family Coach Full
- BEHAVIORAL PTSD Family Coach Basic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
What the finished NCT02486705 record still lists
NCT02486705 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (303% higher).
The record links to 0 conditions, and to 2 interventions - of which PTSD Family Coach Full is the first listed.
NCT02486705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02486705 about?
NCT02486705 is a clinical study titled "Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD". The proposed pilot study is designed to test the feasibility, acceptability, and potential effectiveness of a mobile phone application (app) developed by the VA National Center for PTSD (VA NCPTSD) for use by family members of those with Posttraumatic Stress Disorder (PTSD). The primary objective of...
What is the current status of trial NCT02486705?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 242 participants. The study started on 2015-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02486705?
The interventions under investigation include: PTSD Family Coach Full (BEHAVIORAL), PTSD Family Coach Basic (BEHAVIORAL).
Who is sponsoring clinical trial NCT02486705?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02486705's enrollment target sits among peer trials
242 194th of 2000 higher than 1,805 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia